Infection May Be Trigger for Venous Thromboembolism

Share this content:
Infection May Be Trigger for Venous Thromboembolism
Infection May Be Trigger for Venous Thromboembolism

(HealthDay News) – Older adults recovering from an infection are at increased risk of being hospitalized for a venous thromboembolism (VTE).

In order to evaluate triggers of hospitalization for VTE, Mary A.M. Rogers, PhD, of the University of Michigan in Ann Arbor, and colleagues conducted a case-crossover study. Data for 16,781 participants from the Health and Retirement Study were linked to Medicare records for hospital and nursing home stays; emergency department visits; outpatient visits, including physician visits; and home health visits.

The researchers found infection to be the most common trigger of hospitalization for VTE, occurring in 52.4% of the risk periods prior to hospitalization. The adjusted incidence rate ratios (IRR) were 2.9 for all infection, 2.63 for infection without a prior hospital or skilled nursing facility stay, and 6.92 for infection with a prior hospital or skilled nursing facility stay. In addition, both erythropoiesis-stimulating agents and blood transfusion were associated with VTE hospitalization (IRR, 9.33 and 2.57, respectively). Other predictors included major surgeries, fractures (IRR, 2.81), immobility (IRR, 4.23), and chemotherapy (IRR, 5.7). Together, these predictors accounted for 69.7% of exposures prior to VTE hospitalization, compared with 35.3% in the comparison periods.

"Risk prediction algorithms for VTE should be reevaluated to include infection, erythropoiesis-stimulating agents, and blood transfusion," the authors write.

One author disclosed financial ties to blood technology companies.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters